Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

VSV-tumor selective replication and protein translation.

Oncogene - 21 Nov 2005

Barber Glen N

Abstract excerpt

The emergence of vesicular stomatatis virus (VSV) as a potent antitumor agent has made a dissection of the molecular determinants of host-cell permissiveness to this virus an important objective. Such insight would not only enable the intelligent design of future generations of recombinant VSV vectors to combat disease, but may also resolve general features of cellular transformation that may be exploited by this...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immunity, Innate
Share to Interferons
Share to Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Oncolytic Virotherapy

Share to Oncolytic Viruses

Share to Protein Biosynthesis

Share to Vesicular stomatitis Indiana virus

Share to Virus Replication

Source

Identifiers

PMID: 16299531
DOI: 10.1038/sj.onc.1209042

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

VSV-tumor selective replication and protein translation.PMID 16299531Read ↗

Vesicular Stomatitis Virus as an Oncolytic VectorSemantic proximity Read ↗

Mutations in the glycoprotein of vesicular stomatitis virus affect cytopathogenicity: potential for oncolytic virotherapy.Semantic proximity Read ↗

Oncolytic Activity of Vesicular Stomatitis Virus Is Effective against Tumors Exhibiting Aberrant p53, Ras, or Myc Function and Involves the Induction of ApoptosisSemantic proximity Read ↗

Vesicular stomatitis virus: an exciting new therapeutic oncolytic virus candidate for cancer or just another chapter from Field's Virology?Semantic proximity Read ↗

Immunovirotherapy Based on Recombinant Vesicular Stomatitis Virus: Where Are We?Semantic proximity Read ↗

Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancerSemantic proximity Read ↗

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents.Semantic proximity Read ↗

Oncolytic vesicular stomatitis virus as a treatment for neuroendocrine tumors.Semantic proximity Read ↗

Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapySemantic proximity Read ↗

Induction of apoptosis in pancreatic cancer cells by vesicular stomatitis virus.Semantic proximity Read ↗

Vesicular stomatitis virus infection promotes immune evasion by preventing NKG2D-ligand surface expression.Semantic proximity Read ↗

Autonomous Parvoviruses neither Stimulate nor Are Inhibited by the Type I Interferon Response in Human Normal or Cancer CellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.